ANIP icon

ANI Pharmaceuticals

134 hedge funds and large institutions have $241M invested in ANI Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 44 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

less call options, than puts

Call options by funds: $ | Put options by funds: $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

less ownership

Funds ownership:

26% less capital invested

Capital invested by funds: $325M → $241M (-$83.7M)

27% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 26

Holders
134
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.02M
Puts
$2.08M
Net Calls
Net Calls Change

Top Buyers

1 +$9.54M
2 +$7.47M
3 +$4.62M
4
Morgan Stanley
Morgan Stanley
New York
+$3.7M
5
BlackRock
BlackRock
New York
+$2.28M

Top Sellers

1 -$17.4M
2 -$11M
3 -$8.01M
4
Invesco
Invesco
Georgia
-$6.12M
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.88M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$49.4M
2
$17.8M
3
$16M
4
$9.87M
5
$9.73M
6
$9.67M
7
$9.04M
8
$8.9M
9
$8.86M
10
$5.61M
11
$4.62M
12
$4.53M
13
$4.51M
14
$4.14M
15
$4.05M
16
$3.41M
17
$3.22M
18
$2.48M
19
$2.42M
20
$2.24M
21
$2.24M
22
$2.12M
23
$2.03M
24
$1.97M
25
$1.94M